About Tremor-ataxia-central hypomyelination syndrome
Tremor-ataxia-central hypomyelination syndrome is a rare disease catalogued by Orphanet (ORPHA:447896). It is associated with the POLR3A gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Tremor-ataxia-central hypomyelination syndrome trials.
Search ClinicalTrials.gov for "Tremor-ataxia-central hypomyelination syndrome" or filter by Orphanet code ORPHA:447896 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Tremor-ataxia-central hypomyelination syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Tremor-ataxia-central hypomyelination syndrome. Updated daily.